Skip to content

Search Results

No Results

    Recently Viewed

      Listening...

      Sorry, I don't understand. Please try again

      APAC/About us/Our leadership/Matthias Skillecorn
      updated photos/Matthias Skillecorn.webp

      Matthias Skillecorn

      Vice President, Head of Asia Pacific Strategy Organization (APSO)
      J&J Innovative Medicine, Asia Pacific

      Matthias Skillecorn is VP, Head of Asia Pacific Strategy Organization (APSO) which includes Regional Therapeutic Area Leaders, Market Access and Medical Affairs teams. Matthias is a member of the Innovative Medicine Asia Pacific leadership team.

      Prior to this role, Matthias was Area Managing Director for Janssen Southeast Asia (SEA), leading the cluster of SEA markets as well as a cross-functional SEA cluster team to drive the commercial strategies for Janssen’s portfolio. Matthias previously served as Managing Director for J&J Vietnam from the beginning of 2021, where he led the completion of a business model transformation to a locally recognized Foreign Invested Enterprise. This included restructuring of the pharmaceuticals business to focus on our innovative portfolio, whilst continuing to drive growth of established brands through strategic partnerships with local distributors. These efforts have delivered strong double-digit growth in Vietnam.

      Matthias acted as the Asia Pacific Immunology Therapeutic Area Leader from July 2016 leading significant growth for the Immunology portfolio through multiple new product launches including SIMPONI®, STELARA® in IBD & TREMFYA®. In Early 2020 he took on additional responsibility as the SEA Portfolio Leader, Pharmaceuticals, Southeast Asia in early 2020 leading a team of marketers and acting as a member of the SEA leadership team. With this role he led improved governance and portfolio discipline alongside the SEA Leadership Team, SEA Cross Functional Team and SEA Hospital Council.

      Before moving to his regional roles, Matthias was Immunology Business Unit Director at Janssen Australia and served on the leadership team of Janssen Australia & New Zealand.

      Matthias has over 20 years of experience in the pharmaceutical industry and has held many senior sales and marketing roles at Janssen and, previously, Eli Lilly, working in diverse therapeutic areas including Neuroscience, HIV, Renal, Transplant, Gastroenterology, Dermatology and Rheumatology.

      Matthias was born in Sydney, Australia and holds a Master’s in Business Administration from the University of Technology, Sydney, and a Bachelor of Leisure Studies from the University of New South Wales.